Procutase

an ionic hydrogel composed of natural hydrophilic polymers in an active ionic solution with an inhibitor of matrix metalloproteinases MMP-1, -3 and -9 (collagenase/gelatinase)

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Baldini, R: 1 article (09/2010)
2.	Carini, L: 1 article (09/2010)
3.	Grippaudo, F R: 1 article (09/2010)

Related Diseases

1.	Pain (Aches) 09/01/2010 - "The result of this study showed that Procutase treated patients had statistically significantly less pain and shorter wound healing time. " 09/01/2010 - "Subjects were seen in follow-up biweekly, and wounds of patients in SSD group were compared with those of Procutase group for healing time, pain score at dressing change, compliance with therapy and complication rate. "
2.	Wounds and Injuries (Trauma) 09/01/2010 - "Subjects were seen in follow-up biweekly, and wounds of patients in SSD group were compared with those of Procutase group for healing time, pain score at dressing change, compliance with therapy and complication rate. "
3.	Burns 09/01/2010 - "Procutase can be used successfully in patients with burns that do not require hospital admission." 09/01/2010 - "Procutase versus 1% silver sulphadiazine in the treatment of minor burns." 09/01/2010 - "The purpose of this randomised comparative study was to evaluate the use of silver sulphadiazine (SSD) 1% cream (Group A) with the use of Procutase (Group B) in treating burns with a TBSA <10% and a depth not greater than 2nd degree burns and thus suitable for outpatient management. "

Related Drugs and Biologics

1.	Sulfadiazine (Sulphadiazine)
2.	Silver Sulfadiazine (SSD)
3.	Silver

Related Therapies and Procedures

1.	Therapeutics